HOME >> BIOLOGY >> NEWS
'Snowbirds' versus real birds

The destruction of tropical forests to create vacation resorts for human "snowbirds" who fly south from Canada and the northern U.S. every winter is creating serious breeding problems for real migratory birds, say Queen's University biologists.

A new study, headed by Ph.D. student Ryan Norris and his advisor, Professor Laurene Ratcliffe, shows for the first time that declining winter habitats of migratory songbirds significantly affect their ability to reproduce when they return north in the spring and the evidence is found in tiny drops of their blood.

The study, highlighted recently in the journal Science, and co-authored by Dr. Peter Marra of the Smithsonian Institute, appears on-line in the current Proceedings of the Royal Society: Biological Sciences, and will be published in an upcoming print edition of Proceedings.

"Our findings help explain why many species of long-distance migratory songbirds have declined over the last few decades," says Mr. Norris, noting that a relatively small geographic band across the Caribbean, Greater Antilles, and central America is the annual destination of an estimated five billion migratory birds flying south each year from Canada. The species in this study is a small, migratory warbler called the American redstart.

Until now, understanding how and why these migratory populations are declining has been a problem, since it is difficult to track individuals throughout their yearly travels. A new technique for detecting "biological signatures" provides the solution.

Using equipment and expertise of the Queen's Facility for Isotope Research (QFIR) headed by geology professor Kurt Kyser, the team measures stable carbon isotopes found in the warblers' blood. These samples are taken immediately after the birds arrive at the university's biological field station north of Kingston, Ontario in the spring.

Since the turnover time of the blood cells is from six to eight weeks, they provid
'"/>

Contact: Nancy Dorrance
dorrance@post.queensu.ca
613-533-2869
Queen's University
12-Dec-2003


Page: 1 2

Related biology news :

1. Drugs limit deadly side effects of graft-versus-host disease
2. Infertility treatment versus fertility control: the challenges for developing countries
3. Histone code joins genetic code as critical determinantof chromosomal inheritance: study reveals key properties of silent versus active DNA
4. Mum versus Dad
5. Abgenix initiates phase III clinical trial of graft versus host disease therapy
6. Parasitic cowbirds thrive with a less ruthless strategy than cuckoos
7. A changing landscape may have dire implications for birds
8. Songbirds escaped from Australasia, conquered rest of world
9. Sleepless over Seattle: Migrating songbirds forgo sleep but keep their wits
10. UW study: Migrating birds offer insight into sleep
11. Chemical reaction in birds provides sense of direction during migratory flights

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Snowbirds versus real birds

(Date:10/15/2014)... the 44th Rosenstiel Award for Distinguished Work in Biomedical ... the mechanisms of genomic instability and its implications for ... second alumnus to win the Rosenstiel Award; the first, ... Alt is the Charles A. Janeway Professor of Pediatrics ... an investigator at the Howard Hughes Medical Institute at ...
(Date:10/14/2014)... shows SIRT6—a protein known to inhibit the growth ... skin cancers by turning on an enzyme that increases ... Previously considered protective, SIRT6 is part of a family ... stability and prevent some of the genetic flaws associated ... lead to cancer. This study, in the journal,s October ...
(Date:10/14/2014)... of the planet,s leading questions is how to produce ... variable climate. The Food and Agriculture Organization of the ... over the next 40 years to feed a growing ... the necessary rise in food production. Plants—grains, cereals, ... supporting livestock. Current research must tap into our ...
Breaking Biology News(10 mins):Brandeis awards 44th Rosenstiel Award to pioneering geneticist Fred Alt 2Two-faced gene: SIRT6 prevents some cancers but promotes sun-induced skin cancer 2Building a bridge from basic botany to applied agriculture 2Building a bridge from basic botany to applied agriculture 3
(Date:10/22/2014)... YORK , Oct. 22, 2014 Nuvilex, ... Federation, approximately 400 million people worldwide are living with ... million people by 2030.  The global market for diabetes ... 2012 approximately 330,000 people worldwide died from pancreatic cancer.  ... death due to cancer in the United ...
(Date:10/22/2014)... and HONG KONG , Oct. ... disease therapeutics enterprise, announced today that rare disease expert ... as vice president, research. Dr. McKew brings more than ... leadership positions at the National Institutes of Health, Wyeth ... by Wyeth). Dr. McKew will lead aTyr,s efforts to expand ...
(Date:10/20/2014)... YORK , Oct. 20, 2014 ... their experimental ZMapp™ antibody therapeutic to fight the ... how difficult and time-consuming the production of pharmaceuticals ... market research publisher said that while some may ... of this compound, those with industry knowledge are ...
(Date:10/20/2014)... , Oct. 20, 2014 Asterias ... the Company has signed a Notice of Grant ... Medicine (CIRM), effective October 1, 2014.  The NGA ... payments and the release of additional grant funds ... grant award for clinical development of Asterias, product, ...
Breaking Biology Technology:Nuvilex Brief Analyst Report: Thinking Outside the Box by BrokerBank Securities, Inc. 2aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research 2aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research 3Kalorama: ZMapp Highlights Need For Faster Biopharmaceutical Production 2Kalorama: ZMapp Highlights Need For Faster Biopharmaceutical Production 3Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 4
Cached News: